One dose of Quadrivalent Influenza Virus Vaccine

BIOLOGICAL2 trials

Sponsors

Beijing Chaoyang District Centre for Disease Control and Prevention

Conditions

Quadrivalent Influenza Virus Vaccine

Phase 1

Safety Study of Quadrivalent Influenza Virus Vaccine in Healthy People Aged 3 Years and Older

CompletedNCT02708173

Beijing Chaoyang District Centre for Disease Control and PreventionQuadrivalent Influenza Virus Vaccine

Start: 2016-03-31End: 2016-06-30Updated: 2016-08-15

Phase 3

Safety and Immunogenicity Study of Quadrivalent Influenza Virus Vaccine in Healthy People Aged Years 3-60

Beijing Chaoyang District Centre for Disease Control and PreventionQuadrivalent Influenza Virus Vaccine

Start: 2016-05-31Target: 2400Updated: 2016-06-21